Biomarkers in Barrett's Esophagus.

Techniques in Gastrointestinal Endoscopy
Rhonda F Souza

Abstract

Biomarkers are substances that can be used to indicate normal or diseased states. In clinical settings, the term biomarker generally refers to a molecular marker produced by tissues whose detection heralds a diseased state. For patients with Barrett's esophagus, there are at least three clinical settings in which the use of molecular biomarkers has been proposed including 1) stratifying the risk of neoplastic progression, 2) serving as an adjunct to aid in the diagnosis of dysplasia, and 3) predicting response to ablative therapies. Although the routine clinical use of biomarkers in any of these clinical settings is not yet recommended, it seems reasonable to assume that biomarker validation studies will be carried out in the coming years and that movement into the clinics will be inevitable. This article reviews the current progress in using biomarkers in each of the clinical settings described above with a focus on the molecular biomarkers which have advanced the farthest toward use in routine clinical practice.

References

Jul 19, 2001·Journal of the National Cancer Institute·M S PepeY Yasui
Mar 16, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·V Jon WongsurawatBrian J Reid
Nov 24, 2006·Annals of Surgery·Katerina DvorakHarinder Garewal
Jan 20, 2007·International Journal of Cancer. Journal International Du Cancer·Danielle M GreenawaltWayne A Phillips
Mar 16, 2007·The New England Journal of Medicine·Kaare Christensen, Jeffrey C Murray
Feb 5, 2008·The Journal of Thoracic and Cardiovascular Surgery·Andrew FeberVirginia R Litle
Jun 10, 2008·Gastroenterology·Ganapathy A PrasadLynn S Borkenhagen
Oct 16, 2008·American Journal of Clinical Pathology·Herman van DekkenKees J Vissers
May 27, 2009·Carcinogenesis·Francesco ColottaAlberto Mantovani
Oct 30, 2009·Cell Division·David Y ZhangPeng Lee

❮ Previous
Next ❯

Citations

Aug 21, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Ru-Gang ZhangCun-Fang Gao
Oct 23, 2018·Expert Review of Molecular Diagnostics·Alia P QureshiRobert D Odze

❮ Previous
Next ❯

Related Concepts

Related Feeds

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.